An observational study in Traumatic Brain Injury and Post-traumatic Stress Disorder, sponsored by International Hyperbaric Medical Foundation. Terminated at 10 sites in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2016-09-20.
Sponsored by International Hyperbaric Medical Foundation · Observational
This is an observational research study whose purposes are to see:
2,113 studies on the registry are indexed under Brain Injuries; 385 are open to participants now.
This study's enrollment of 133 is above the median of 100 across 690 observational studies indexed under Brain Injuries.
Browse Brain Injuries studies →This is the only study on the registry with International Hyperbaric Medical Foundation as lead sponsor.
Counted across the registry records on this site, refreshed daily.
One thousand subjects will be recruited. Subjects will be 18-65 years old and have been diagnosed with mild or moderate (but not severe) TBI or TBI/PTSD or PTSD by either the military (any etiology) or civilian neurologists or neuropsychologists. This diagnosis will especially include war veterans who have had a significant decrease in their neuropsychological test scores.
There will be no gender restriction. However, it is anticipated that the cohort will consist mostly of males, due to the nature of the injury. There will be no race or ethnicity restriction.
All subjects will be legally capable of consenting. No subjects who need 3rd party consent will be enrolled in the NBIRR study.
Military - Unless specifically approved by a military site IRB, active duty participants will have to voluntarily contact NBIRR participating sites or respond to a recruitment outreach outside of the command.
Exclusion Criteria:
Cognitive Function
Time frame: 2-6mo then every 6 months for 2yrs
This study is terminated, as verified in Sep 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.